MPS Pharma Ltd

NSE: ADVIKLA · BSE: 531686 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹2.08
Market cap: ₹3.98 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-1.02 Cr
P/E (TTM): -3.8×Sector 43.8×
Promoter holding: 35.89%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Board Meeting Date 4 Financial Results 3 Annual General Meeting 2 Management Change 1 Debt & Borrowing 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

1 Oct 2026 15:23 IST BSE

Management Change

MPS Pharma Management Change

MPS Pharmaa Limited announced the appointment of Anchal Goyal as an Independent Director for a five-year term. The company also re-appointed Ram Niwas Sharma and statutory auditors Nemani Garg Agarwal & Co.

Open announcement → Read the filing ↗